Molecular characterization of extended-spectrum beta-lactamase producing Enterobacteriaceae in a Saudi Arabian tertiary hospital

Journal of Infection in Developing Countries

Volumn 8, Issue 3, 2014, Pages 282-288

  Hassan, Hoda ^a,b   Abdalhamid, Baha ^a  

^a KING FAHAD SPECIALIST HOSPITAL   (Saudi Arabia)

^b ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

CTX M; Enterobacteriaceae; ESBL

Indexed keywords

AMIKACIN; BETA LACTAMASE AMPC; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLACTX-M GENE; BLASHV GENE; BLATEM GENE; CONTROLLED STUDY; EPSILOMETER TEST; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; GENE; GENE SEQUENCE; GENETIC SCREENING; HUMAN; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR PATHOLOGY; MOLECULAR TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PREVALENCE; PROTEUS MIRABILIS; SAUDI ARABIA; SENSITIVITY AND SPECIFICITY;

BETA-LACTAMASES; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; HUMANS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEUS MIRABILIS; SAUDI ARABIA; TERTIARY CARE CENTERS;

EID: 84896098410     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.3809     Document Type: Article

References (44)

1. Livermore DM, Hawkey PM (2005) CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother 56: 451-454.
2. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, Ayala J, Coque TM, Kern-Zdanowicz I, Luzzaro F, Poirel L, Woodford N (2007) CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 59: 165-174.
3. Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18: 657-686.
4. Canton R, Coque TM (2006) The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 9: 466-475.
5. Bonnet R (2004) Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48: 1-14.
6. Bradford PA (2001) Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14: 933-951.
7. Ramphal R, Ambrose PG (2006) Extended-spectrum beta-lactamases and clinical outcomes: current data. Clin Infect Dis 42 Suppl 4: S164-172.
8. Sturenburg E, Mack D (2003) Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect 47: 273-295.
9. M'Zali FH, Chanawong A, Kerr KG, Birkenhead D, Hawkey PM (2000) Detection of extended-spectrum beta-lactamases in members of the family enterobacteriaceae: comparison of the MAST DD test, the double disc and the Etest ESBL. J Antimicrob Chemother 45: 881-885.
10. Grimm V, Ezaki S, Susa M, Knabbe C, Schmid RD, Bachmann TT (2004) Use of DNA microarrays for rapid genotyping of TEM beta-lactamases that confer resistance. J Clin Microbiol 42: 3766-3774.
11. Saito R, Koyano S, Nagai R, Okamura N, Moriya K, Koike K (2010) Evaluation of a chromogenic agar medium for the detection of extended-spectrum ss-lactamase-producing Enterobacteriaceae. Lett Appl Microbiol 51: 704-706.
12. El-Khizzi NA, Bakheshwain SM (2006) Prevalence of extended-spectrum beta-lactamases among Enterobacteriaceae isolated from blood culture in a tertiary care hospital. Saudi Med J 27: 37-40.
13. Kader AA, Angamuthu K (2005) Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia. Saudi Med J 26: 956-959.
14. Kader AA, Kumar A, Kamath KA (2007) Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect Control Hosp Epidemiol 28: 1114-1116.
15. Panhotra BR, Saxena AK, Al-Ghamdi AM (2004) Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome. Saudi Med J 25:.1871-1876
16. Tawfik AF, Alswailem AM, Shibl AM, Al-Agamy MH (2011) Prevalence and genetic characteristics of TEM, SHV, and CTX-M in clinical Klebsiella pneumoniae isolates from Saudi Arabia. Microb Drug Resist 17: 383-388.
17. Al-Agamy MH, Shibl AM, Tawfik AF (2009) Prevalence and molecular characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Ann Saudi Med 29: 253-257.
18. Cormican MG, Marshall SA, Jones RN (1996) Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen. J Clin Microbiol 34: 1880-1884.
19. Hornsey M, Phee L, Woodford N, Turton J, Meunier D, Thomas C, Wareham DW (2013) Evaluation of three selective chromogenic media, CHROMagar ESBL, CHROMagar CTX-M and CHROMagar KPC, for the detection of Klebsiella pneumoniae producing OXA-48 carbapenemase. J Clin Pathol 66: 348-350.
20. Pitout JD, Thomson KS, Hanson ND, Ehrhardt AF, Moland ES, Sanders CC (1998) beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa. Antimicrob Agents Chemother 42: 1350-1354.
21. Randall LP, Kirchner M, Teale CJ, Coldham NG, Liebana E, Clifton-Hadley F (2009) Evaluation of CHROMagar CTX, a novel medium for isolating CTX-M-ESBL-positive Enterobacteriaceae while inhibiting AmpC-producing strains. J Antimicrob Chemother 63: 302-308.
22. Paterson DL, Hujer KM, Hujer AM, Yeiser B, Bonomo MD, Rice LB, Bonomo RA, International Klebsiella Study Group (2003) Extended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV-and CTX-M-type beta-lactamases. Antimicrob Agents Chemother 47: 3554-3560.
23. Woodford N, Fagan EJ, Ellington MJ (2006) Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases. J Antimicrob Chemother 57: 154-155.
24. Pfeifer Y, Matten J, Rabsch W (2009) Salmonella enterica serovar Typhi with CTX-M beta-lactamase, Germany. Emerg Infect Dis 15: 1533-1535.
25. Huseyin T, Hakki B (2005) Molecular characterization of TEM-and SHV-derived extended-spectrum beta-lactamases in hospital-based Enterobacteriaceae in Turkey. Jpn J Infect Dis 58: 162-167.
26. Lumbreras-Lacarra B, Ramos-Rincón JM, Hernández-Aguado I (2004). Methodology in diagnostic laboratory test research in clinical chemistry and clinical chemistry and laboratory medicine. Clin Chem 50: 530-536.
27. Hawkey PM (2008) Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect 14 Suppl 1: 159-165.
28. Gur D, Hascelik G, Aydin N, Telli M, Gultekin M, Ogulnc D, Arikan OA, Uysal S, Yaman A, Kibar F, Gulay Z, Sumerkan B, Esel D, Kayacan CB, Aktas Z, Soyletir G, Altinkanat G, Durupinar B, Darka O, Akgun Y, Yayla B, Gedikoglu S, Sinirtas M, Berktas M, Yaman G (2009) Antimicrobial resistance in gram-negative hospital isolates: results of the Turkish HITIT-2 Surveillance Study of 2007. J Chemother 21: 383-389.
29. Perez F, Endimiani A, Hujer KM, Bonomo RA (2007) The continuing challenge of ESBLs. Curr Opin Pharmacol 7: 459-469.
30. Al-Zarouni M, Senok A, Rashid F, Al-Jesmi SM, Panigrahi D (2008) Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Med Princ Pract 17: 32-36.
31. Mokaddas EM, Abdulla AA, Shati S, Rotimi VO (2008) The technical aspects and clinical significance of detecting extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary-care hospital in Kuwait. J Chemother 20: 445-451.
32. Feizabadi MM, Delfani S, Raji N, Majnooni A, Aligholi M, Shahcheraghi F, Parvin M, Yadegarinia D (2010) Distribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran. Microb Drug Resist. 16: 49-53.
33. Khanfar HS, Bindayna KM, Senok AC, Botta GA (2009) Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings. J Infect Dev Ctries 3: 295-299. doi:10.3855/jidc.127
34. Bilal NE, Gedebou M (2000) Clinical and community strains of Klebsiella pneumoniae: multiple and increasing rates of antibiotic resistance in Abha, Saudi Arabia. Br J Biomed Sci 57: 185-191.
35. Kader AA, Kumar A (2005) Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital. Ann Saudi Med 25: 239-242.
36. Fam N, Leflon-Guibout V, Fouad S, Aboul-Fadl L, Marcon E, Desouky D, El-Defrawy I, Abou-Aitta A, Klena J, Nicolas-Chanoine MH (2011) CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings. Microb Drug Resist 17: 67-73.
37. Shahcheraghi F, Moezi H, Feizabadi MM (2007) Distribution of TEM and SHV beta-lactamase genes among Klebsiella pneumoniae strains isolated from patients in Tehran. Med Sci Monit 13: BR247-250.
38. Bindayna K, Khanfar HS, Senok AC, Botta GA (2010) Predominance of CTX-M genotype among extended spectrum beta lactamase isolates in a tertiary hospital in Saudi Arabia. Saudi Med J 31: 859-863.
39. Sonnevend A, Al Dhaheri K, Mag T, Herpay M, Kolodziejek J, Nowotny N, Usmani A, Sheikh FA, Pal T (2006) CTX-M-15-producing multidrug-resistant enteroaggregative Escherichia coli in the United Arab Emirates. Clin Microbiol Infect 12: 582-585.
40. Ensor VM, Jamal W, Rotimi VO, Evans JT, Hawkey PM (2009) Predominance of CTX-M-15 extended spectrum beta-lactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait. Int J Antimicrob Agents 33: 487-489.
41. Mohamed Al-Agamy MH, El-Din Ashour MS, Wiegand I (2006) First description of CTX-M beta-lactamase-producing clinical Escherichia coli isolates from Egypt. Int J Antimicrob Agents 27: 545-548.
42. Dashti AA, Jadaon MM, Gomaa HH, Noronha B, Udo EE (2010) Transmission of a Klebsiella pneumoniae clone harbouring genes for CTX-M-15-like and SHV-112 enzymes in a neonatal intensive care unit of a Kuwaiti hospital. J Med Microbiol 59: 687-692.
43. Farber J, Moder KA, Layer F, Tammer I, Konig W, Konig B (2008) Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium. J Clin Microbiol 46: 3721-3727.
44. Leverstein-van Hall MA, Fluit AC, Paauw A, Box AT, Brisse S, Verhoef J (2002) Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. J Clin Microbiol 40: 3703-3711.